We have proposed recently that the DO3A-N-α-(amino)propionate chelator and its amide conjugates are leads to targeted, high relaxivity, safe contrast agents for magnetic resonance imaging. In this work we illustrate further the expeditious nature and robustness of the synthetic methodologies developed by preparing the DO3A-N-(α-pyrenebutanamido)propionate chelator. Its Gd 3+ chelate retains the optimized water exchange, high stability and inertness of the parent complex. The pyrene moiety imparts concentration-dependent self-assembly properties and aggregation-sensitive fluorescence emission to the Gd This report demonstrates that the DO3A-N-(α-amino)propionate chelator is a valuable platform for constructing high relaxivity CA using simple design principles and robust chemistries accessible to most chemistry labs.
Introduction
Positron emission tomography (PET), single photon emission correlated tomography (SPECT), magnetic resonance imaging (MRI), ultra sound (US), and X-ray computerized axial tomography (CAT) are imaging modalities used nowadays regularly in hospitals for diagnostic and prognostic purposes. 1 MRI has become in recent years the most useful imaging modality in the clinical setup. This results from its superb spatial resolution, use of non-ionizing radiation (radiofrequencies and magnetic fields), depth independent imaging and the possibility of repeated imaging to offset the low detection sensitivity of MRI which is intrinsic to the nuclear magnetic resonance phenomenon. Signal intensity differences in MRI (contrast) arise mainly from intrinsic differences of the relaxation times (T 1,2 ) of the water protons of tissues. The contrast between normal and diseased tissues can be dramatically improved by paramagnetic contrast agents (CA) (Gd 3+ , Mn 2+ , stable nitroxide radicals, iron oxide nanoparticles, etc.), which shorten the relaxation times of the water protons. 2 Relaxivity (r 1,2 ), which is the paramagnetic enhancement of water proton relaxation rates R 1,2 (R 1,2 = 1/T 1,2 ) normalized to 1 mM concentration, measures CA efficacy. 2, 3 The currently used CAs for T 1 -weighted MRI imaging are Gd 3+ chelates of linear (DTPA-type)
or macrocyclic (DOTA-type) poly(aminocarboxylate) chelators. † Electronic supplementary information (ESI) available: Size distribution in: (a) volume (%); (b) intensity (%) for a GdL solution (5 mM, pH 7.0, 25°C) at a concentration well above the cmc (0.6 mM) (Fig. S1 ); temperature dependence of the water proton relaxivity for GdL (20 MHz, 1 mM, pH 6.0) (Fig. S2) ; pH dependence of the water proton relaxivity for GdL (20 MHz, 1 mM, 25°C) (Fig. S3) ; time evolution of R 1p (t )/R 1p (0) (20 MHz, pH 7.1, 25°C) for a 1.5 mM solution of GdL in 10 mM phosphate buffer without and with an equimolar amount of Zn 2+ (Fig. S4) ; UV-Vis spectra for the free ligand L and the GdL complex (Fig. S5) ; fluorescence spectra for the free ligand L in non-deoxygenated water ( pH 7.0) over the concentration range 5 × 10 (Table S1) ; biodistribution of 153 SmL in Wistar rats 1 and 24 hours after i.v. injection (Table S2) ; equations for the analysis of 1 Due to its long electronic relaxation times and high paramagnetism, Gd 3+ efficiently enhances T 1 relaxation, resulting in signal intensity enhancement and bright images -positive contrast. 4 High relaxivity CA can lead to T 1 reductions sufficient to generate effective contrast at low doses. Moreover, delivering CA to diseased areas can allow further dose reduction. Effective contrast at low CA doses (CAs in clinical use are normally used at a dose of 0.1 mmol kg −1 ) became more important recently with the identification of the nephrogenic systemic fibrosis (NSF) which is a debilitating and even deadly condition associated with in vivo Gd 3+ release from
Gd-based CAs. 5 In fact, free (non-complexed) Gd 3+ (and all the other Ln 3+ ions) are acutely toxic. Most NSF cases have been associated with the use of Gd 3+ DTPA-type complexes, particularly Gd(DTPA-bis-amide) CA. 6 Low thermodynamic stability and kinetic lability, coupled to slow kidney clearance, results in extensive complex demetallation in vivo. 7 Macrocyclic, DOTA-type Gd 3+ complexes are generally considered safe given their higher thermodynamic stability and kinetic inertness. 8 Chelates displaying simultaneous optimization of the molecular parameters that govern relaxivity, namely the rotational correlation time (τ R ), the water exchange rate (k ex = 1/τ M ) and the electronic relaxation parameters, are expected to display very high relaxivities. 9 There are well established strategies for tuning τ R and k ex into the optimal range to attain high relaxivities at intermediate fields relevant for clinical MRI. Tuning the Gd 3+ ion electronic relaxation parameters turns out to be more challenging. 10 Increasing the molecular weight of chelates leads to longer rotational correlation times (τ R ) (slower tumbling rates) enhancing CA relaxivity at intermediate fields.
Self-assembly of amphiphilic chelates into micelle-type supramolecular structures, 11 non-covalent association with serum albumin 12 and covalent attachment of chelates to macromolecular and nanoobjects ( proteins, 13 Endowing targeted high relaxivity Gd 3+ chelates with a fluorescence reporting capability results in bimodal MRI/fluorescence imaging agents. This approach has the potential to improve CA performance: the high detection sensitivity of fluorescence complements the low detection sensitivity of MRI, whilst the depth independent properties of MRI complement the limited light crossing into live tissues. We have recently described methodologies for the synthesis of the DO3A-N-(α-amino)propionate chelator and for preparing its amide conjugates. 18, 21 Gd 3+ complexes of those amide conjugates retain the optimal water exchange, high stability and kinetic inertness of the parent complex. 18 In this work we describe the synthesis of the pyrenebutyric acid conjugate of the DO3A-N-(α-amino)propionate chelator and its Ln 3+ complexes. The effect of self-assembly on the relaxivity and fluorescence properties of the Gd[(DO3A-N-(α-pyrenebutanamido)-propionate)] complex was studied by relaxometry and steady state fluorescence. The potential of the pyrene moiety to sensitize NIR emitting Ln 3+ ions has also been addressed.
Results and discussion

Synthesis
The DO3A-N-(α-pyrenebutanamido)propionate chelator (L) was synthesised following the (indirect) methodology proposed before for amide conjugates of the DO3A-N-(α-amino)propionate chelator (Scheme 1).
The N-(α-pyrenebutanamido)propionate pendant group was introduced, early on the synthesis, into the cyclen scaffold via Michael addition of the dehydroalanine (Pyrene, Boc)-Δ-AlaOMe reactive block (4) . Synthetic block (4) was prepared in 2 steps in 70% overall yield following the procedure developed by Ferreira and co-workers (Scheme 2). 33 After removing the tert-butyloxycarbonyl protecting group from the monoalkylated intermediate (6) with TFA, one pot N-alkylation of the cyclen scaffold with ethyl bromoacetate afforded prochelator 7. Alkaline deprotection of 7 with Dowex 1X2-OH − resin, followed by resin elution with diluted hydrochloric acid, afforded the DO3A-N-(α-pyrenebutanamido)-propionate chelator (L) as hydrochloride in 30% overall yield over 3 steps. Recently, Caravan and co-workers have reported a similar pathway for the synthesis of conjugates of the DO3A-N-(α-amino)propionate chelator. 34 The synthesis of the DO3A-N-(α-pyrenebutanamido)propionate chelator further supports the use of the indirect pathway for amide conjugates of the DO3A-N-(α-amino)propionate chelator.
Relaxometric studies of the GdL complex
The concentration dependence of the paramagnetic water proton relaxation rate (R 1p ) was evaluated for GdL (20 MHz, 25°C, pH 7.0) in the concentration range 0.05-5.0 mM (Fig. 1) . The paramagnetic longitudinal relaxation rate data vs.
[GdL] define two straight lines with different slopes. This behaviour is characteristic of chelate self-assembly in aqueous solution, presumably into micelle-type structures, driven by the hydrophobic effect. 11 The break point gives an estimation of the critical micelle concentration, cmc (0.60 ± 0.02 mM), for GdL. Below the cmc, the complex is in a monomeric, nonaggregated form in solution (eqn (1)). Above the cmc, it is present in the form of aggregates as well as monomers whose concentration corresponds to the cmc (eqn (2) concentration.
The micellar nature of GdL above the cmc (5.0 mM, pH 7.0) was confirmed by dynamic light scattering (DLS) analysis (Fig. S1 †) . A bimodal intensity distribution, with the main population of particles displaying an average radius of 1.7 nm and a minor population exhibiting an average radius of 73 nm, was obtained by DLS, resulting in a population weighted mean hydrodynamic radius, expressed by the z-average parameter, of 49 nm. The temperature (Fig. S2 †) and pH dependences (Fig. S3 †) of the paramagnetic water proton relaxation rate were studied at 20 MHz. Transmetallation studies against Zn 2+ ions were also performed to evaluate the kinetic inertness of the complex (Fig. S4 †) . The temperature dependence study strongly suggests that below 50°C, the relaxivity is not limited by slow water exchange. The pH-dependence and the transmetallation studies indicate that the GdL complex, like its non-associating Gd[(DO3A-N-(α-benzoylamido)propionate)] analogue, is stable towards protonation-assisted demetallation and inert towards transmetallation with Zn 2+ . 21 
O NMR and 1 H NMRD studies
The magnetic field dependence of the longitudinal water proton relaxivities ( 1 H NMRD profiles) of GdL was recorded at 25°C and 37°C in the frequency range 0.01 to 80 MHz and at concentrations below ( Fig. 3) and above (Fig. 2c ) the cmc. The NMRD curves are influenced by many parameters, the most important being the hydration number (q), the water exchange rate (k ex ), the electron relaxation parameters (τ v and Δ 2 ) and the rotational correlation time (τ R ). The NMRD measurements have been completed with 17 O NMR data ( Fig. 2a and b The proton relaxation rates measured above the cmc represent the sum of the relaxivity contribution of the monomer complex, present at a concentration equal to the cmc, and the relaxivity contribution of the aggregated state. In order to calculate the relaxivity of the aggregated form, the relaxivity contribution of the monomer has been subtracted from the relaxation rates measured above the cmc. These profiles present the characteristic high field peak typical of slowly tumbling Gd 3+ complexes. The 17 O NMR measurements have been performed at 5.0 mM concentration, largely above the cmc (0.6 mM). Under these conditions, one can consider that the rotational dynamics, as assessed by 17 O T 1 data, corresponds to the micellar state. Therefore, the 17 O NMR data have been fitted together with the NMRD curves of the micellar state to the Solomon-Bloembergen-Morgan theory by including the Lipari-Szabo treatment for the description of the rotational motion (Table 1) . 35 In this approach, two kinds of motion are assumed to modulate the interaction causing the relaxation, namely a rapid, local motion which lies in the extreme narrowing limit and a slower, global motion. We calculate therefore τ g , the correlation time for the global motion (common to the whole micelle), and τ l , the correlation time for the fast local motion, which is specific for the individ- The NMRD profile for the monomeric form is characteristic of low molecular weight complexes (Fig. 3) . The relaxivity at intermediate field (5.9 mM
by fast rotation in solution as indicated by the short τ R value obtained (116 ps). In contrast, above the cmc the NMRD profile of GdL displays a hump at intermediate field, typical of slow tumbling species (Fig. 2c) . 11, 15, 35 The relaxivity decreases with increasing temperature, indicating that it is not limited by slow water exchange. The same behaviour was previously observed for gold nanoparticles functionalised with the analogous cysteine conjugate Gd[(DO 3 A-N-(α-cystamido)propionate)]. 15 The water exchange rate on GdL is similar to that reported for the low molecular weight amide analogue Gd[(DO 3 A-N-(α-benzoylamido)propionate)] 21 and slightly higher than that reported for the parent Gd[(DO 3 A-N- 37 and Gd (DOTAMAP-En-C18) 38 (S 2 = 0.24 and 0.28, respectively) ( Fig. 4 and (GAC 12 ) 2 )], respectively). The high relaxivity attained by GdL can be thus ascribed to simultaneous optimization of τ R and k ex . The optimization of the rotational dynamics of complexes has been firmly established for relaxivity enhancement at intermediate fields. The simultaneous optimization of τ R and k ex is far more demanding and often achieved at the expense of complex stability compromising potential biological applications. This study highlights the importance of simultaneous optimization of all molecular parameters in order to attain high relaxivities and provides further support for our claim that amide conjugates of the DO3A-N-α-aminopropionate chelator are valuable synthons for constructing high relaxivity safe CA for MRI.
Luminescence studies
The Gd[(DO 3 A-N-(α-pyrenebutanamido)propionate)] complex was designed as a bimodal MRI/fluorescence probe. The pyrene fluorophore was selected to impart self-assembly Table 2 and discussed in the text. properties and concentration-dependent fluorescence reporting capability to the paramagnetic complex. 27 The absorption (Fig. S6 †) and the fluorescence emission properties (Fig. S7 †) of the free ligand L and the GdL complex were studied in non-deoxygenated water ( pH 7.0) at concentrations well below the cmc by UV-Vis and steady-state fluorescence spectroscopy (Table 3) .
At concentrations below the cmc (cmc = 2.7 mM for L, see below, and 0.6 mM for GdL), L and GdL display similar absorption spectra in the region characteristic of pyrene (300-350 nm) assigned to intraligand π-π* transitions. 32 Selective irradiation of the pyrene chromophore on L and GdL at 345 nm yields fluorescence spectra displaying vibronically structured features, assigned to intraligand 1 π-π* transitions, characteristic of pyrene monomer emission (Fig. S5 †) . 32, 41 At the concentration studied (well below the cmc), no excimer emission (broad featureless band with an emission with an apparent maximum located at 490-500 nm) was observed for both the free ligand and the Gd 3+ complex. The fluorescence quantum yields for L and for the pyrene-centred emission in GdL are of the same order of magnitude as those reported for other pyrene conjugates.
Complex formation with paramagnetic Gd 3+ seems to have only a minor effect on the fluorescence quantum yield of L.
41
We envisaged that it could be possible to monitor the selfassembly process of L and GdL by taking advantage of the aggregation-sensitive fluorescence properties of the pyrenyl moiety. 27 With this aim, we studied by steady-state fluorescence the effect of the concentration on the fluorescence properties of L (Fig. S7 †) and GdL (Fig. 5) .
For low micromolar concentrations of L and GdL, the fluorescence spectra display the characteristic vibronically structured pyrene monomer emission band. For higher (low millimolar) concentrations, the intensity of the monomer emission band is reduced and a new broad, red-shifted, featureless band, assigned to excimer formation, appears. The concentration dependence of the ratio of fluorescence emission intensity for the excimer (490 nm) and for the monomer (377 nm) (I E /I M ) was used to determine independently the cmc for L (Fig. S7 †) and GdL (Fig. 5) by fitting the experimental data points to a sigmoidal curve model (Table S1 †) . 42, 43 A cmc value of approximately 0.64 mM, in excellent agreement with the value determined by relaxometry (0.60 mM), was derived for GdL from the fluorescence study (Fig. 5) . A much higher cmc value (2.7 mM) was determined for the free ligand (Fig. S7 †) , reflecting the ionization state (multi-charged) of the free metal chelator. Below the cmc, the ligand and the complex are molecularly dissolved and the fluorescence arises from the decay of excited monomers. Above the cmc, fluorescence emission arises predominantly from the decay of excited dimers -excimers. Higher concentrations of GdL increase the number of micelles and enhance excimer formation and the corresponding fluorescence emission intensity. Two different mechanisms have been established for excimer emission: diffusive encounter of an excited monomer with a ground state molecule and the direct excitation of ( preassociated) ground state dimers. The partitioning of the different modes of excimer formation depends on the fluidity of the micelle environment. Time-resolved fluorescence experiments suggest that the diffusive mechanism is the main contributor to excimer formation in cationic gemini surfactants containing a pyrene moiety and a long alkyl chain. 44 The order parameter determined for the micellar form of GdL (S 2 = 0.24)
indicates that the micelles are fluid, suggesting that the diffusive mechanism might be responsible for excimer formation. Deciphering the mechanism of excimer formation in GdL micelles is outside the scope of the present study. The pyrene-centered fluorescence of GdL effectively provides this complex with MRI/fluorescence bimodal imaging agent activity. From a practical point of view, the pyrene centred fluorescence of GdL could be used for imaging studies in small Inset -changes in the emission properties of GdL as the ratio of the fluorescence emission intensity for the excimer (I E , 490 nm) and for the monomer (I M , 377 nm) (I E /I M ) as a function of GdL concentration. Table 3 Maximum absorption (λ abs ) and emission wavelengths (λ em ), molar extinction coefficients (ε) and fluorescence quantum yields (Φ F ) for ligand L and GdL complex (λ ex 345 nm) in non-deoxygenated water at concentrations below the cmc plexes are similar to each other and match well the profile of the corresponding absorption spectra as an indication that the sensitization of the lanthanide luminescence is occurring through the same electronic levels centred on pyrene.
Interaction of GdL with human serum albumin (HSA)
Self-assembly of chelates into supramolecular structures (as discussed in this work) and binding to serum albumin (HSA) are robust strategies to enhance chelate relaxivity via optimization of τ R . In addition to relaxivity enhancement, self-assembly and binding of chelates to HSA slow down CA leakage into the interstitial compartment, providing an extended time window for vasculature imaging (MRI angiography). 47 The binding affinity of GdL to HSA was assessed by Proton Relaxation Enhancement (PRE) measurements. The PRE methods are tailored to determine the differences in the NMR water solvent relaxation rates between protein-bound (resulting in an increase of the relaxation rates) and free substrates. Experimentally, it consists of measuring the water proton relaxation rates R obs 1 in solution at increasing concentrations of the protein while keeping the concentration of the metal chelate constant (E-titration) or vice versa (M-titration). The data obtained for the E-titration using a GdL concentration below the cmc (0.1 mM) and increasing HSA concentrations (Fig. 7) were fitted to a one site binding model (eqn (S1) †).
The fitting affords an estimation of the relaxivity of the HSA-bound form, r 1 : 1 binding isotherm in interpreting the relaxometric data for albumin binding of Gd 3+ complexes. 51 In fact, most often relaxometric data alone do not allow for distinguishing between different binding models. An independent evaluation of K A and n may be, in principle, pursued through the analysis of the data obtained from an M-titration, in which a fixed concentration of HSA is titrated with the Gd 3+ complex. The titration of 4% HSA with GdL is restricted to the narrow range of concentrations below cmc precluding a quantitative analysis of the data. The interaction of GdL with HSA is prone to modulate the biodistribution of GdL as recently reported for similar conjugates.
12,52
Biodistribution studies
The biodistribution profile of GdL was obtained after 1 and 24 hours post-injection ( pi) using the 153 Sm 3+ -labelled surrogate complex ( Fig. 8 and Table S2 †) . A recent patent claims that peptides derivatised with pyrene are able to cross the blood-brain barrier thanks to ( presumably) a correct lipophylicity/hydrophylicity balance imparted by the pyrene moiety. 53 This intriguing possibility was considered during the biodistribution study. The 153 SmL chelate displays biodistribution profiles at 1 and 24 hours pi similar to other micellar systems. 54 After 1 hour pi there is substantial activity in the blood, liver, spleen and lungs. The high activity in the blood after 1 hour pi reflects the micellar nature of the CA and its strong association with HSA, which slows down leakage of the complex into the interstitial compartment. The complex follows both hepatic and renal elimination. The hepatic and spleen uptake reflects the micellar nature of the CA and the role played by resident macrophages in the liver and spleen (Reticulo Endothelial System, RES) in clearing particulate material from the blood. The activity in the lungs might again reflect the retention of particulate material in narrow blood vessels and the extensive vascularisation of that organ and thus the high blood content of the lungs. The increase in activity in the spleen and liver after 24 hours pi correlates with the activity clearance from the blood and lungs, suggesting particle retention on those organs. Interestingly, after 1 hour pi, a low activity is measurable in the brain/cerebellum, suggesting that the complex might cross the blood-brain barrier. This possibility deserves further investigation.
Conclusions
The pyrenebutyric acid conjugate of the DO3A-N-(α-amino)propionate chelator was synthesised following synthetic methodologies reported previously by us. 55 In summary, we have reported recently that Gd 3+ complexes of amide conjugates of the DO3A-N-(α-amino)propionate chelator are new leads for targeted, high relaxivity, safe CA for in vivo MRI. 21 In this work we provide further evidence to support this claim using simple design principles and robust chemistry accessible to all laboratories.
Experimental
Materials and methods
Chemicals were purchased from Sigma-Aldrich and used without further purification. Solvents used were of reagent grade and purified by usual methods. Cyclen was purchased from CheMatech, France. Reactions were monitored by TLC on Kieselgel 60 F254 (Merck) on an aluminium support. Detection was done by examination under UV light (254, 365 nm) and by adsorption of iodine vapour. Flash chromatography was performed on a Kieselgel 60 (Merck, mesh 230-400). The relevant fractions from flash chromatography were pooled and concentrated under reduced pressure, T < 313 K. Ion exchange chromatography was performed on Dowex 1X2-100-OH − resin (Sigma Aldrich). The resin was purchased as the Cl − form and converted to the OH − form by treatment with aqueous NaOH. 1 internal
29).
Synthesis of methyl 3-hydroxy-2-(4-( pyren-1-yl)butanamido)-propanoate (3). To a solution of HCl, H-Ser-OMe (1) (5.0 mmol, 0.778 g) and triethylamine (10 mmol) in acetonitrile (5.0 mL) were added 1-pyrenebutyric acid (2) (5.0 mmol, 1.44 g), 1-hidroxybenzotriazole (HOBt) (5.0 mmol, 0.675 g) and dicyclohexylcarbodiimide (DCC) (5.5 mmol, 1.13 g). The reaction mixture was left stirring at room temperature for 18 hours. The reaction mixture was filtered and the solvent was removed under reduced pressure. The residue was dissolved in ethyl acetate (100 mL), washed with KHSO 4 1 M, NaHCO 3 1 M and brine (3 × 30 mL each) and dried over MgSO 4 . The solvent was removed to give 3 (1.70 g, 87%) as a yellow oil. 1 
Synthesis of methyl 2-[N-(tert-butoxycarbonyl)-4-( pyren-1-yl)-butanamido]acrylate (4).
To a solution of Pyr-Ser-OMe (3) (5.0 mmol, 1.95 g) in dry acetonitrile (5.0 mL) were added 4-dimethylaminopyridine (DMAP) (1.7 mmmol, 0.213 g) and tert-butyldicarbonate (17.5 mmol, 3.82 g). The reaction mixture was left stirring at room temperature for 24 hours. The solvent was removed under reduced pressure and the residue was dissolved in ethyl acetate (100 mL). The organic layer was washed with KHSO 4 1 M, NaHCO 3 1 M and brine (3 × 30 mL, each), dried over MgSO 4 and the solvent removed under reduced pressure to give 4 (1.91 g, 81%) as a yellow oil. 1 Synthesis of (2-(N-t-butoxycarbonyl)pyrenebutyramido)-methoxycarbonylethyl-1,4,7,10-tetrazacyclododecane (monoalkylated cyclen) (6). K 2 CO 3 (1.47 g, 10.6 mmol) was added to a solution of cyclen (5) Synthesis of 2-pyrenebutyramido-methoxycarbonylethyl-4,7,10-tris-(ethoxycarbonylmethyl)-1,4,7,10 tetrazacyclododecane (tetraalkylated cyclen) (7) . A solution of monoalkylated cyclen (6) (0.860 g, 1.33 mmol) in trifluoroacetic acid in dichloromethane (60%, 25 mL) was stirred overnight at room temperature. The solvent was evaporated at reduced pressure and the residue was re-dissolved in dichloromethane. This procedure was repeated several times to give a light yellow thick oil. 1 
O NMR experiments
Variable-temperature 17 O NMR measurements were performed using a Bruker Avance-500 (11.7 T) spectrometer. A BVT-3000 temperature control unit was used to stabilize the temperature, measured by a substitution technique. The samples were sealed in glass spheres that fitted into 10 mm o.d. NMR tubes to eliminate susceptibility corrections to the chemical shifts. 58 Longitudinal relaxation rates (1/T 1 ) were obtained by the inversion recovery method, and transverse relaxation rates (1/T 2 ) by the Carr-Purcell-Meiboom-Gill spin-echo technique. Acidified water, pH 3.4, was used as the external reference.
NMRD measurements
The measurements were performed using a Stelar Spinmaster FFC NMR relaxometer (0.01-20 MHz) equipped with a VTC90 temperature control unit. At higher fields, the 1 H relaxivity measurements were performed on a Bruker electromagnet at frequencies of 30 MHz, 40 MHz, 60 MHz and 80 MHz. In each case, the temperature was measured by a substitution technique. Variable temperature measurements were performed at 25 and 37°C.
Relaxivity studies of pH dependence and Zn 2+ transmetallation
The transmetallation reaction of GdL with Zn 2+ was studied by following the time dependent decrease of the water proton longitudinal relaxation rate, R 1 , of a phosphate-buffered saline solution (PBS, pH 7.1, 10 mM) containing 1.5 mM of GdL after adding an equimolar amount of ZnCl 2 while the sample was vigorously stirred. 59 The water longitudinal relaxation rate was also measured as a function of time on the PBS buffered solution ( pH 7.1, 10 mM) containing 2.5 mM GdL. 60 The pH dependence of the relaxivity of the GdL solution was studied by adjusting ( pH meter) the pH of a 1 mM solution of GdL in water with either NaOH or HCl solutions using a pH meter. A Bruker Minispec mq20 (20 MHz, 298 K) relaxometer was used for all measurements.
Fluorescence measurements
The absorption and the ligand-based fluorescence emission spectra of the free ligand L and the GdL complex were recorded, respectively, using a Jasco V-630 UV-Vis spectrophotometer and a HORIBA JobinYvon Fluoromax-4 spectrofluorimeter, equipped with a monochromator in both excitation and emission and a temperature controlled cuvette holder. Fluorescence spectra were corrected for the instrumental response of the system. The fluorescence quantum yields (Φ s ) were determined using a standard method. 61, 62 Groups of four animals (Wistar male rats weighing ca. 200 g) were anaesthetized with ketamine (50.0 mg mL −1 )/ chloropromazine (2.5%) (10 : 3) and injected in the tail vein with ca. 100 μCi of the tracer. Animals were sacrificed 1 and 24 hours later and the major organs were removed, weighed and counted in a γ well-counter.
Size distribution
The size distribution of particles in a (micellar) solution of GdL at a concentration well above the cmc (5.0 mM, pH 7.0) was determined with a Malvern Zetasizer, NANO ZS (Malvern Instruments Limited, UK) using an He-Ne laser (λ = 633 nm) and a detector angle of 173°. The GdL solution in a polystyrene cell (1 mL) was analysed at 25°C. The mean hydrodynamic radius (z-average) and a width parameter for the distribution, polydispersity or polydispersity index (PdI) were calculated from the intensity of the scattered light. In the present work, the intensity-based z-average parameter was considered the best approach to the actual particle size.
Data analysis
Data obtained from 17 O NMR, 1 H NMRD, Luminescence and Quantum Yield measurement studies were processed using OriginLab Pro 8 SRO. Data from relaxometric and transmetallation studies were processed using Microsoft Office Excel 2007.
